- Home
- PMT vs ORIC Comparison
PMT vs ORIC Comparison
Compare PMT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PMT | ORIC |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PMT | ORIC |
|---|---|---|
| Price | $12.24 | $10.62 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 13 |
| Target Price | $13.67 | ★ $19.73 |
| AVG Volume (30 Days) | 1.5M | ★ 1.9M |
| Earning Date | 01-29-2026 | 02-18-2026 |
| Dividend Yield | ★ 13.22% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.99 | N/A |
| Revenue | ★ $721,170,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $29.66 | N/A |
| P/E Ratio | $12.23 | ★ N/A |
| Revenue Growth | ★ 42.92 | N/A |
| 52 Week Low | $11.60 | $3.90 |
| 52 Week High | $14.93 | $14.93 |
Technical Indicators
Market Signals| Indicator | PMT | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 40.15 | 48.17 |
| Support Level | $11.70 | $10.14 |
| Resistance Level | $13.64 | $11.51 |
| Average True Range (ATR) | 0.41 | 0.82 |
| MACD | -0.17 | -0.11 |
| Stochastic Oscillator | 28.27 | 11.33 |
Price Performance
Historical ComparisonAbout PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.